Skip to content

Mediterranean diet adherence linked to recurrence-related outcomes after cancer

Cohort studies linked closer adherence after diagnosis with lower hazards of recurrence or cancer-specific death. Randomized trials gave an inconclusive result for fatigue.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Closer adherence to a Mediterranean diet after cancer diagnosis was associated with lower hazards of recurrence or cancer-specific death in observational studies. This cannot establish that diet caused the difference. The separate randomized evidence on cancer-related fatigue was statistically inconclusive, leaving uncertainty about whether fatigue changed in the populations studied.

Keep in mind

Few studies informed each outcome, and methods varied. This abstract-based summary lacks follow-up durations and the fatigue scale's identity; the observational recurrence evidence cannot establish causation.

THE NUMBERS, WITH CONTEXT

What researchers found

Hazard ratio 0.83

Recurrence or cancer-specific death

Higher post-diagnosis adherence; 95% confidence interval 0.70-0.99. Comparator categories and follow-up duration were not reported.

Nutrients, 2026 · Original source ↓

Reading the hazard ratio

A hazard ratio compares how quickly events occur over time; one is the no-difference reference. Here, 0.83 indicates a lower relative hazard of recurrence or cancer-specific death. It does not specify the absolute probability of either event.

Fatigue had different evidence

Fatigue was assessed in randomized trials, whereas recurrence evidence came from cohorts. The pooled fatigue estimate was not statistically significant and had substantial uncertainty. That leaves room for effects the available trials could not resolve.

CHECK THE ORIGINAL

The original publication

Post-Diagnosis Adherence to the Mediterranean Diet and Cancer Recurrence and Fatigue Outcomes in Cancer Survivors, with Emphasis on Colorectal Cancer: A Systematic Review and Meta-Analysis.

Papamichael D, Felekkis K, Andreou EP
Nutrients · 2026

PubMed ID
41829977
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.